Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 28.

Derungs, R; Camici, G G; Spescha, R D; Welt, T; Tackenberg, C; Späni, C; Wirth, F; Grimm, A; Eckert, A; Nitsch, R M; Kulic, L (2017). Genetic ablation of the p66(Shc) adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease. Molecular Psychiatry, 22(4):605-614.

Spescha, R D; Klohs, J; Semerano, A; Giacalone, G; Derungs, R S; Reiner, M F; Rodriguez Gutierrez, D; Mendez-Carmona, N; Glanzmann, M; Savarese, G; Kränkel, N; Akhmedov, A; Keller, S; Mocharla, P; Kaufmann, M R; Wenger, R H; Vogel, J; Kulic, L; Nitsch, R M; Beer, J H; Peruzzotti-Jametti, L; Sessa, Maria; Lüscher, Thomas F; Camici, G G (2015). Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke. European Heart Journal, 36(25):1590-1600.

Reiner, M F; Martinod, K; Stivala, S; Savarese, G; Camici, G G; Lüscher, T F; Wagner, D D; Beer, J H (2015). Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice. Thrombosis and Haemostasis, 113(1):177-184.

Spescha, R D; Shi, Y; Wegener, S; Keller, S; Weber, B; Wyss, M M; Lauinger, N; Tabatabai, G; Paneni, F; Cosentino, F; Hock, C; Weller, M; Nitsch, R M; Lüscher, T F; Camici, G G (2013). Deletion of the ageing gene p66Shc reduces early stroke size following ischaemia/reperfusion brain injury. European Heart Journal, 34(2):96-103.

Breitenstein, A; Sluka, S H; Akhmedov, A; Stivala, S; Steffel, J; Camici, G G; Riem, H H; Beer, H J; Studt, J D; Duru, F; Luscher, T F; Tanner, F C (2012). Dronedarone reduces arterial thrombus formation. Basic Research in Cardiology, 107(6):302.

Holy, E W; Forestier, M; Richter, E K; Akhmedov, A; Leiber, F; Camici, G G; Mocharla, P; Lüscher, T F; Beer, J H; Tanner, F C (2011). Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(8):1772-1180.

Breitenstein, A; Stein, S; Holy, E W; Camici, G G; Lohmann, C; Akhmedov, A; Spescha, R; Elliott, P J; Westphal, C H; Matter, C M; Lüscher, T F; Tanner, F C (2011). Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovascular Research, 89(2):464-472.

Camici, G G; Shi, Y; Cosentino, F; Francia, P; Lüscher, T F (2011). Anti-aging medicine: molecular basis for endothelial cell-targeted strategies - a mini-review. Gerontology, 57(2):101-108.

Gebhard, C; Stähli, B E; Shi, Y; Camici, G G; Akhmedov, A; Hoegger, L; Lohmann, C; Matter, C M; Hassa, P O; Hottiger, M O; Malinski, T; Lüscher, T F; Tanner, F C (2011). Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction. Biochemical and Biophysical Research Communications (BBRC), 414(4):641-646.

Holy, E W; Stämpfli, S F; Akhmedov, A; Holm, N; Camici, G G; Lüscher, T F; Tanner, F C (2010). Laminin receptor activation inhibits endothelial tissue factor expression. Journal of Molecular and Cellular Cardiology, 48(6):1138-1145.

Gebhard, C; Breitenstein, A; Akhmedov, A; Gebhard, C E; Camici, G G; Lüscher, T F; Tanner, F C (2010). Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. European Heart Journal, 31(14):1780-1791.

Stämpfli, S F; Akhmedov, A; Gebhard, C; Lohmann, C; Holy, E W; Rozenberg, I; Spescha, R; Shi, Y; Lüscher, T F; Tanner, F C; Camici, G G (2010). Aging induces endothelial dysfunction while sparing arterial thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(10):1960-1967.

Shi, Y; Camici, G G; Lüscher, T F (2010). Cardiovascular determinants of life span. Pflügers Archiv: European Journal of Physiology (Pflugers Archiv), 459(2):315-324.

Asmis, L; Tanner, F C; Sudano, I; Lüscher, T F; Camici, G G (2010). DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? Biochemical and Biophysical Research Communications (BBRC), 391(4):1629-16333.

Camici, G G; Steffel, J; Amanovic, I; Breitenstein, A; Baldinger, J; Keller, S; Lüscher, T F; Tanner, F C (2010). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European Heart Journal, 31(2):236-242.

Gebhard, C; Akhmedov, A; Mocharla, P; Angstenberger, J; Sahbai, S; Camici, G G; Lüscher, T F; Tanner, F C (2009). PDGF-CC induces tissue factor expression: role of PDGF receptor alpha/beta. Basic Research in Cardiology, 105(3):349-356.

Gebhard, C; Stämpfli, S F; Gebhard, C E; Akhmedov, A; Breitenstein, A; Camici, G G; Holy, E W; Lüscher, T W; Tanner, F C (2009). Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis. Basic Research in Cardiology, 104(3):285-294.

Camici, G G; Sudano, I; Noll, G; Tanner, F C; Lüscher, T F (2009). Molecular pathways of aging and hypertension. Current Opinion in Nephrology and Hypertension, 18(2):134-137.

Stähli, B E; Camici, G G; Tanner, F C (2009). Drug-eluting stent thrombosis. Therapeutic Advances in Cardiovascular Disease, 3(1):45-52.

Breitenstein, A; Camici, G G; Tanner, F C (2009). Tissue factor: beyond coagulation in the cardiovascular system. Clinical Science, 118(3):159-172.

Breitenstein, A; Stämpfli, S F; Camici, G G; Akhmedov, H R; Ha, H R; Follath, F; Bogdanova, A; Lüscher, T F; Tanner, F C (2008). Amiodarone inhibits arterial thrombus formation and tissue factor translation. Arteriosclerosis Thrombosis and Vascular Biology, 28(12):2231-2238.

Camici, G G; Cosentino, C; Tanner, F C; Lüscher, T F (2008). The role of p66Shc deletion in age-associated arterial dysfunction and disease states. Journal of Applied Physiology, 105(5):1628-1631.

Osto, E; Matter, C M; Kouroedov, A; Malinski, T; Bachschmid, M; Camici, G G; Kilic, U; Stallmach, T; Boren, J; Iliceto, S; Lüscher, T F; Cosentino, F (2008). c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation, 118(20):2073-2080.

Cosentino, F; Francia, P; Camici, G G; Pelicci, P G; Lüscher, T F; Volpe, M (2008). Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arteriosclerosis Thrombosis and Vascular Biology, 28(4):622-628.

von Lukowicz, T; Hassa, P O; Lohmann, C; Borén, J; Braunersreuther, V; Mach, F; Odermatt, B; Gersbach, M; Camici, G G; Stähli, B E; Tanner, F C; Hottiger, M O; Lüscher, T F; Matter, C M (2008). PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovascular Research, 78(1):158-166.

Camici, G G (2008). What is an optimal stent? Biological requirements of drug eluting stents. Kardiovaskuläre Medizin, (1):22-25.

Stähli, B E; Breitenstein, A; Akhmedov, A; Camici, G G; Shojaati, K; Bogdanov, N; Steffel, J; Ringli, D; Lüscher, T F; Tanner, F C (2007). Cardiac glycosides regulate endothelial tissue factor expression in culture. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(12):2769-2776.

Camici, G G; Stallmach, T; Hermann, M; Hassink, R; Doevendans, P; Grenacher, B; Hirschy, A; Vogel, J; Lüscher, T F; Ruschitzka, F; Gassmann, M (2007). Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Methods in Enzymology, 435:147-155.

This list was generated on Tue Dec 12 07:40:17 2017 CET.